EUVIMEDEUVIMED entdecken
Open Access

Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo

Limei Shen, Alison Schaefer, Justin Huckaby, Whitney Wolf, Samuel K Lai

Theranostics · 13.04.2025 · 15 (12) · 5529-5542

DOI: 10.7150/thno.103372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 13.04.2025. Verfasst von Limei Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Carcinoma, Pancreatic Ductal, T-Lymphocytes, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificCarcinoma, Pancreatic DuctalT-LymphocytesCarcinoma, Non-Small-Cell LungLung NeoplasmsPancreatic NeoplasmsLectinsMembrane ProteinsAnimalsHumansMiceCell Line, TumorLymphocyte ActivationTumor MicroenvironmentCD3 ComplexXenograft Model Antitumor AssaysFemaleMice, Inbred NODImmunotherapyImmunoglobulins

Stichwörter der Autor:innen

bispecific T cell engager (biTE)immunotherapytumor microenvironment

Substanzen

Antibodies, BispecificSIGLEC15 protein, humanLectinsCD3 ComplexMembrane ProteinsImmunoglobulins

Autor:innen und Institutionen

  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA.
  • Department of Biomedical Engineering, University of North Carolina at Chapel Hill, NC, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA.
  • Department of Immunology and Microbiology, University of North Carolina at Chapel Hill, NC, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Shen, L., Schaefer, A., Huckaby, J., Wolf, W., & Lai, S. K. (2025). Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. Theranostics, 15(12), 5529-5542. https://doi.org/10.7150/thno.103372

Vancouver

Shen L, Schaefer A, Huckaby J, Wolf W, Lai SK. Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. Theranostics. 2025;15(12):5529-5542. doi:10.7150/thno.103372

BibTeX
@article{Shen2025,
  author = {Shen, Limei and Schaefer, Alison and Huckaby, Justin and Wolf, Whitney and Lai, Samuel K},
  title = {Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {5529--5542},
  doi = {10.7150/thno.103372}
}
Kostenlos starten →